Induction of plasma (TRAIL), TNFR-2, Fas ligand, and plasma microparticles after human immunodeficiency virus type 1 (HIV-1) transmission: implications for HIV-1 vaccine design.

Source:http://linkedlifedata.com/resource/pubmed/id/18508902

Download in:

View as

General Info

PMID
18508902